ACHVAchieve Life SciencesACHV info
$3.69info-3.40%24h
Global rank20981
Market cap$78.10M
Change 7d-9.78%
YTD Performance-12.14%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Achieve Life Sciences (ACHV) Stock Overview

    Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

    ACHV Stock Information

    Symbol
    ACHV
    Address
    1040 West Georgia StreetVancouver, BC V6E 4H1Canada
    Founded
    -
    Trading hours
    -
    Website
    https://www.achievelifesciences.com
    Country
    🇨🇦 Canada
    Phone Number
    604 210 2217

    Achieve Life Sciences (ACHV) Price Chart

    -
    Value:-

    Achieve Life Sciences Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.69
    N/A
    Market Cap
    $78.10M
    N/A
    Shares Outstanding
    21.17M
    N/A
    Employees
    20.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org